Showing 181 - 199 results of 199 for search '"Hematology"', query time: 0.08s Refine Results
  1. 181

    Effects of Celery Seed Extracts on Some Haematological and Biochemical Parameters in Albino Rats Treated with Gentamicin by Tavga Ismael Mustafa, Zhakaw Khudir Abdullah, Nazar Mohammed Shareef Mahmood, Shorish Mustafa Abdullah Gorony, Kurdo Bapir Chato, Ranjbar Muksy Mohammed Shareef

    Published 2019-08-01
    “…The present study targeted the influence of orally celery seeds (Apium graveolens) aqueous extract and ethanolic extracts on male albino rats injected with gentamicin intraperitoneally to investigate some hematological and biochemical parameters. Thirty-two male rats were weighing 300-400 gm carried out for the present research, they controlled environmentally. …”
    Get full text
    Article
  2. 182
  3. 183

    Measurement the Physiological Properties of Water Pipe Smokers in Shekhan Distract by Abdullah. M. Al-Saiegh, Turki Sabri Haji, Jihan Saado Ahmed, Alaa Azzo Aslo, Firas Faris Khalaf

    Published 2019-08-01
    “…Sample had been taken through blood collection from 100 who are water pipe smoker and 100 who not smoke, and this include the following physiological test: Heart Rate, Blood Pressure, and Respiratory Flow Rate, in addition with laboratory hematological test Hemoglobin. The results showed an increase in the rate of (Blood pressure, Inspiratory Flow Rate, Heart rate, Hemoglobin) and rates higher after smoking as follow for Blood Pressure after smoking systolic was141.9±6.021 and diastolic 91.75 ±4.459 While the inspiratory flow rate reading after smoking 963.5 ±96.624, the heart rate reading after smoking was  83.27 ±7.84 while the hemoglobin the reading was 15.68 ±0.87 as recorded after finishing smoking . …”
    Get full text
    Article
  4. 184

    PARP inhibitors as therapy for small cell lung carcinoma: A systematic review and meta-analysis of clinical trials by Samuel Pratama, Lowilius Wiyono, Martien Silviandy Setiawan, Brigitta Cindy Lauren

    Published 2024-01-01
    “…The analysis showed increased Progression-Free Survival (PFS) (RR 0.92 (95 %CI 0.84–1.00; p=0.05)) and Objective Response Rate (ORR) (RR 1.27 (95 %CI 1.07–1.50; p=0.007)), no significant difference in Overall Survival (OS) (RR 1.03 (95 %CI 0.92–1.15; p=0.60)), and an increased risk for serious Treatment Emergent Adverse Events (TEAEs) (RR 1.13 (95 %CI 0.95–1.35; p=0.16)) in PARPi-receiving SCLC patients. Amongst the hematologic toxicities, sub-analysis showed that thrombocytopenia had the highest risk, followed by neutropenia, anemia, leukopenia, and lymphopenia. …”
    Get full text
    Article
  5. 185
  6. 186

    Escherichia coli in septic arthritis: prevalence and antibiotics susceptibility patterns by Masroora Ali Khan, Muhammad Kamran Taj, Zahid Khan, Imran Taj, Muhammad Naeem, Saima Azam

    Published 2025-02-01
    “…Joint aspirates (2ml) and blood (5ml) were analyzed for microbial and hematological examination. Results: There were 5.45% samples positive, and 94.5% negative for E. coli. …”
    Get full text
    Article
  7. 187

    Machine learning identifies the association between second primary malignancies and postoperative radiotherapy in young-onset breast cancer patients. by Yulin Lai, Peiyuan Huang

    Published 2025-01-01
    “…YWBC patients receiving PORT had significantly greater risks of second primary solid malignancies (SPSMs, RR = 1.61), including breast cancer (RR = 1.89), lung cancer (RR = 2.12) and thyroid cancer (RR = 1.48), but not second primary hematologic malignancies (RR = 1.32; 0.94-1.88). SPSMs were more common in YWBC individuals who were black, had a lower median household income and had fewer lymph nodes examined. …”
    Get full text
    Article
  8. 188

    Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain by María Teresa Gómez-Casares, Juan Carlos Hernández-Boluda, Antonio Jiménez-Velasco, Joaquin Martínez-López, María Giovanna Ferrario, Irmina Gozalbo, Joana Gostkorzewicz, Rudi Subirá

    Published 2017-11-01
    “…**Introduction:** Primary myelofibrosis (MF) is a rare hematologic disease belonging to the group of Philadelphia-negative chronic myeloproliferative neoplasms. …”
    Get full text
    Article
  9. 189

    Epidemiological Characteristics and Family Relatives among Thalassemic Patients in Sulaimani City, Kurdistan Region, Iraq by Kamal Jalal Rashid

    Published 2018-07-01
    “…Thalassemia is a well-known inherited hematologic disorder caused by a decrease or an absence of globin production. …”
    Get full text
    Article
  10. 190

    A Retrospective Observational Cohort Analysis of Oncology Patients with Febrile Neutropenia in the Emergency Department of a Tertiary Care Hospital in Oman by Badar Al-Aamri, Aisha AL Breiki, Darpanarayan Hazra, Talib Al-Aamri, Manar Al-Shehi

    Published 2025-01-01
    “…Of these, 52.9% were classified as low risk, with 44.6% having hematological malignancies and 55.4% having solid malignancies. …”
    Get full text
    Article
  11. 191

    Laparoscopic Versus Abdominal Myomectomy Postoperative Outcomes by Nicel Taşdemir, Cem Çelik, Remzi Abalı, Ayşegül Kayalı, Abdulaziz Gül, Özkan Özdamar

    Published 2014-04-01
    “…Not observing any differences in variations of hematologic parameters supports the idea that the time is lost during the morcellation. …”
    Get full text
    Article
  12. 192

    Estimation of median LC50 and toxicity of environmentally relevant concentrations of thiram in Labeo rohita by Sana Alam, Gulnaz Afzal, Riaz Hussain, Hafiz Muhammad Ali, Amtul Sami, Rabbiah Manzoor Malik, Raheela Jabeen, Farid Shokry Ataya, Kun Li

    Published 2025-02-01
    “…There observed a significant (p < 0.05) decrease in the body weight while a significant increase in the relative (p < 0.05) and absolute (p < 0.05) weights of kidneys, heart and brain was found. Hematological analysis showed a significant (p < 0.05) increase in leukocytes and neutrophils while lymphocytes and monocytes, RBCs and hemoglobin concentration were significantly (p < 0.05) decreased. …”
    Get full text
    Article
  13. 193

    Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries by Anas Hamad, Shereen Elazzazy, Ruba Y. Taha, Hani Osman, Sana Alblooshi, Islam Elkonaissi, Mustaqeem A. Siddiqui, Khalil Al-Farsi, Mohammed Al Lamki, Sali Emara, Gihan H. Elsisi

    Published 2024-07-01
    “…**Background:** The second most common hematologic cancer worldwide is multiple myeloma (MM), with incidence and mortality rates that have more than doubled over the past 30 years. …”
    Get full text
    Article
  14. 194

    The Effects of Adverse Events and Associated Costs on Value-Based Care for Metastatic Pancreatic Ductal Adenocarcinoma by Prachi Bhatt, Jared Hirsch, Paul Cockrum, George Kim, Gabriela Dieguez

    Published 2024-12-01
    “…The development of any studied hematologic AE was associated with a mean excess cost of $5993 per administration, while the development of any studied nonhematological AE was associated with a mean per-administration excess cost of $3665. …”
    Get full text
    Article
  15. 195

    Association between Loa loa microfilaremia and anatomical hyposplenia in a rural area of the Republic of Congo: a population-based cross-sectional study by Charlotte Boullé, Elodie Lebredonchel, Jérémy T. Campillo, Valentin Dupasquier, Marlhand C. Hemilembolo, Sébastien D. S. Pion, Jean Claude Djontu, Ludovic Rancé, Philippe Souteyrand, François Missamou, Michel Boussinesq, Francine Ntoumi, Cédric B. Chesnais

    Published 2025-02-01
    “…Blood samples were analyzed for L. loa MFD, Plasmodium-PCR, Anti-Plasmodium falciparum-IgG, total IgM, sickle-cell disease status, and hematological abnormalities. Linear and logistic regressions were used to assess these associations. …”
    Get full text
    Article
  16. 196
  17. 197

    Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysis by Roberto Buonaiuto, Aldo Caltavituro, Margherita Tafuro, Alessandra Longobardi, Giuliana Pavone, Pierluigi De Santis, Roberta Caputo, Carmine De Angelis, Lucia Del Mastro, Fabio Puglisi, Mario Giuliano, Grazia Arpino, Martina Pagliuca, Michelino De Laurentiis

    Published 2025-02-01
    “…Interestingly, a numerically higher rate of treatment-related hematological toxicity was observed in Asian patients, although no significant interethnic difference was found in the relative risk of these events. …”
    Get full text
    Article
  18. 198

    Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients by YANG Xingdong, YU Muyang, XU Yiming, ZHU Wei, HU Mingwei, WENG Xisheng, FENG Bin

    Published 2025-01-01
    “…After propensity score matching, 163 cases from SLE and control groups were included for analysis. (1) Regarding medical complications, compared with control group, SLE group showed significant differences in osteoporosis, respiratory system disorders, gastrointestinal diseases, urinary system disorders, hematologic abnormalities, and secondary or concomitant rheumatic diseases (all P < 0.05). (2) In terms of preoperative laboratory tests, SLE group had lower platelet counts, absolute lymphocyte counts, hemoglobin levels, hematocrit, albumin levels, blood glucose levels, and activated partial thromboplastin times than control group, while C-reactive protein, erythrocyte sedimentation rate, and D-dimer levels were higher (all P < 0.05). (3) Regarding surgical-related indicators, a higher proportion of patients in SLE group had an ASA grade > 2 (15.95% vs. 3.07%, P < 0.001), but intraoperative blood loss was significantly smaller [324.7 (200.0, 500.0) mL vs. 421.8 (200.0, 500.0) mL, P=0.005]. (4) In terms of complications, SLE group exhibited a significantly higher incidence of major complications than control group (8.59% vs. 1.23%, P=0.005), with a relative risk of 1.081 (95% CI: 1.028-1.136). …”
    Get full text
    Article
  19. 199